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Mutations in the human DNA methyltransferase 3B (DNMT3B) gene lead to ICF
(immunodeficiency, centromeric region instability, and facial anomalies) syndrome type I.
We have previously described a telomere-related phenotype in cells from these
patients, involving severe hypomethylation of subtelomeric regions, abnormally short
telomeres and high levels of telomeric-repeat-containing RNA (TERRA). Here we
demonstrate that ICF-patient fibroblasts carry abnormally short telomeres at a low
population doubling (PD) and enter senescence prematurely. Accordingly, we attempted
to rescue the senescence phenotype by ectopic expression of human telomerase,
which led to elongated telomeres with hypomethylated subtelomeres. The senescence
phenotype was overcome under these conditions, thus dissociating subtelomeric-DNA
hypomethylation per se from the senescence phenotype. In addition, we examined
whether the subtelomeric methylation could be restored by expression of a normal
copy of full length DNMT3B1 in ICF fibroblasts. Ectopic expression of DNMT3B1 failed
to rescue the abnormal hypomethylation at subtelomeres. However, partial rescue of
subtelomeric-hypomethylation was achieved by co-expression of DNMT3B1 together with
DNA methyltransferase 3-like (DNMT3L), encoding a protein that functions as a stimulator
of DNMT3A and DNMT3B. DNMT3B1 and DNMT3L are predominantly expressed during
early embryonic development, suggesting that de novo subtelomeric DNA methylation
during crucial stages of human embryonic development may be necessary for setting and
maintaining normal telomere length.
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INTRODUCTION
Immunodeficiency, centromeric instability and facial anomalies
(ICF) syndrome type I is a rare autosomal recessive disorder
caused by mutations in DNA methyltransferase 3B (DNMT3B)
(Hansen et al., 1999; Okano et al., 1999a; Xu et al., 1999;
Wijmenga et al., 2000; Rigolet et al., 2007; Hagleitner et al.,
2008). DNMT3B, in concert with DNMT3A, carries out de novo
methylation of the genome during early stages of embryonic
development in mammals (Okano et al., 1999b; Bestor, 2000;
Robertson, 2002; Chen et al., 2003; Ueda et al., 2006). Several
DNA repeat regions in the human genome were found to be
targets of DNMT3B, among them human centromeric regions
and human satellite 2 and 3 repeats that are positioned at the
juxtacentromeric heterochromatin regions of human chromo-
somes 1, 9, and 16 (Jeanpierre et al., 1993; Xu et al., 1999; Kondo
et al., 2000; Tuck-Muller et al., 2000; Tsien et al., 2002; Rigolet
et al., 2007; Heyn et al., 2012). Hypomethylation of satellite 2 and
3 repeats is associated with decondensation of these regions,
leading to centromeric instability, one of the hallmarks of this
syndrome (Jeanpierre et al., 1993; Xu et al., 1999; Tuck-Muller
et al., 2000; Gisselsson et al., 2005) reviewed in Ehrlich (2003). In
mouse models of ICF syndrome, minor satellite repeats, situated
in vicinity of all mouse centromeres, are similarly found to
be hypomethylated (Dodge et al., 2005; Velasco et al., 2010).
Previously we and others have shown that human subtelomeric
regions are additional targets of DNMT3B (Yehezkel et al., 2008;
Deng et al., 2010).
Telomeres in vertebrates are composed of the hexameric repeat
(TTAGGG)n (Moyzis et al., 1988). The subtelomeric regions,
which reside immediately proximal to the telomeric repeats, con-
tain other families of repetitive DNA (Riethman et al., 2005).
Human telomere length at birth is ∼15 kb on average, but it is
highly variable among individuals (Moyzis et al., 1988). Gradual
attrition of telomere length occurs with aging in vivo and with
cell culture passages in vitro, due at least in part to the “end-
replication problem” (Baird, 2008). When telomeres reach an
average length of ∼3 kb, cells enter a state of replicative senes-
cence (Allsopp andHarley, 1995). Embryonic and adult stem cells
mitigate the attrition in telomere length through the activity of
telomerase, an RNA-protein complex that elongates shortened
telomeres by reverse transcription (Shay, 1997; Bekaert et al.,
2004).
Telomeric and subtelomeric regions in many plants and ani-
mals are packaged as constitutive heterochromatin (Chan and
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Blackburn, 2002). In mammalian cells, telomeric and subtelom-
eric regions, similar to centromeric regions, are marked by tri-
methylation of histone H3 at Lysine 9 and histone H4 at Lysine
20, low levels of acetylation of histones H3 and H4 (reviewed
in Blasco, 2004, 2007) and binding of heterochromatin pro-
tein1 alpha (Blasco, 2004, 2007). While the dinucleotide CG
is absent from the mammalian TTAGGG repeat, human sub-
telomeric regions are rich in CG sites (Cross et al., 1990; De
Lange et al., 1990; Brock et al., 1999). Similar to other human
(Jeanpierre et al., 1993; Qu et al., 1999; Kondo et al., 2000;
Tuck-Muller et al., 2000; Tsien et al., 2002) and mouse (Ponzetto-
Zimmerman andWolgemuth, 1984; Sanford et al., 1984; Feinstein
et al., 1985) repetitive sequences, human subtelomeric regions are
hypomethylated in sperm and oocytes and are heavily methy-
lated de novo during development (Cross et al., 1990; De Lange
et al., 1990; Brock et al., 1999). Recently is has been shown
that, although devoid of genes and packaged as heterochro-
matin, subtelomeric, and telomeric regions have the potential to
transcribe telomeric repeat-containing RNA (TERRA), also des-
ignated Telomeric RNA (TelRNA) (Azzalin et al., 2007; Schoeftner
and Blasco, 2008).
The important role that epigenetic regulatory modifications
play in the stability of chromosome ends is emphasized by the
telomeric disorders that occur when these modifications are dis-
rupted (Blasco, 2007; Schoeftner and Blasco, 2009). Such is the
case in ICF syndrome type I where hypomethylated subtelom-
eric regions are associated with short telomere length, advanced
replication timing, high levels of TERRA and abnormal his-
tone modifications (Yehezkel et al., 2008; Deng et al., 2010).
It is unknown, however, whether similar to other genetic dis-
eases, such as dyskeratosis congenita (DKC), in which telomere
maintenance is disrupted (Dokal, 2011), the reduced telom-
ere length detected in ICF fibroblasts contributes to premature
senescence, and whether induced telomere elongation may res-
cue the telomere-related phenotypes in these cells. In addition,
it is unknown whether ectopic expression of DNMT3B in non-
embryonic cells of ICF syndrome patients, may restore normal
methylation patterns at subtelomeric regions.
Here we show that ICF fibroblasts exhibit very short telomeres
already at a very low population doubling (PD). These cells pre-
maturely enter cellular senescence and expression of telomerase
can rescue this phenotype. On the other hand, introduction of
wild type DNMT3B failed to restore normal subtelomeric methy-
lation in ICF fibroblasts. Additional expression of an embry-
onically expressed co-factor of DNMT3B, DNMT3L, partially
restored methylation levels at subtelomeric regions. Based on
these findings we suggest that de novomethylation of target repet-
itive regions, including subtelomeric regions, by DNMT3B in
human cells can occur only during a certain interval in the course
of embryonic development, and the failure to methylate sub-
telomeres in this window, results in abnormal maintenance of
telomere length during subsequent development.
MATERIALS AND METHODS
PATIENT MUTATION DESCRIPTION
Primary fibroblasts from two ICF type I patients were studied.
Fibroblasts from one patient were obtained from Coriell Institute
for Cell Research (GM08747). In previous studies (Yehezkel et al.,
2008, 2011) and in the current study, we refer to this patient as
pCor. This patient (Carpenter et al., 1988) is a heterozygote com-
pound for mutations in DNMT3B (Hansen et al., 1999; Okano
et al., 1999a). The first mutation is Ala603Thr (positioned in
the catalytic domain) and the second mutation is an insertion of
three amino acids (SerThrPro) upstream to amino acid 807 due
to a IVS22-11G->A mutation, creating a new splice acceptor site
nine nucleotides upstream to the normal acceptor site. Fibroblasts
from a second patient pG, previously described (Turleau et al.,
1989), were obtained from Evani Viegas-Péquignot. This patient
is also a compound heterozygote for mutations in DNMT3B.
The first mutation is a c122DupT leading to a frame shift after
amino acid 41 (Ile), resulting in a stop codon after 41 amino
acids (pILE41fsX42). The second mutation is a missense muta-
tion in the catalytic domain (Ser780Leu). All codon and amino
acid changes are depicted according to the full-length transcript
of DNMT3B (ENST00000328111).
CELL CULTURE
Primary fibroblasts from the two ICF patients were cultured in
MEM supplemented with 20% FCS, glutamine and antibiotics.
Every 4–7 days, cells were subcultured to maintain a continuous
log phase growth and the PD was determined. pCor fibroblasts
infected with human catalytic subunit of telomerase (hTERT),
designated pCor + hTERT, control FSE, and FSE + hTERT
fibroblasts (described previously in Yehezkel et al., 2008) were
grown under similar conditions. FSE fibroblasts were obtained
from a foreskin of a week-old newborn.
RETROVIRAL INFECTIONS
pG fibroblasts were serially infected with a pBABE-eGFP con-
struct containing the catalytic subunit of telomerase, hTERT, as
described previously (Yalon et al., 2004). These cells were des-
ignated pG + hTERT. pCor + hTERT and pG + hTERT cells
were serially infected with a pBABE-puromycin construct (pcl)
containing the humanDNMT3B gene (described below). Control
cells were infected with an empty pcl plasmid. Cells that incorpo-
rated these constructs were selected with 2μg/ml puromycin.
pCor + hTERT + DNMT3B1 cells were serially infected with
a pBABE-neomycin construct containing the human DNMT3L
gene (described below). Control cells were infected with an
empty pBABE-neomycin plasmid. Cells that incorporated these
constructs were selected with 400μg/ml G418.
CONSTRUCTION OF GENE-CONTAINING-RETROVIRALVECTORS
Cloning of DNNMT3B1 into pBABE-puromycin
Total RNA from the human embryonic stem (hES) cell line,
H9.1, was extracted with TRI REAGENT (Molecular Research
Center, Inc.) and converted to cDNA using SuperScript
III reverse transcriptase (Invitrogen life technologies). PCR
was performed on the cDNA with the following oligonu-
primer containing the underlined BamHI site) and
ing the underlined EcoRI site). The PCR product was digested
and cloned into the BamHI and EcoRI sites of the pBABE-puro
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AAGAATTCTCTGCCACACACCCCAG (reverse primer contain-
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(pcl) vector and its sequence was verified by sequencing of both
strands.
Cloning of DNMT3L into pBABE-neomycin
PCR of H9.1 hES cDNA was carried out with the
(Forward primer containing the underlined EcoRI site) and
taining the underlined SalI site). The PCR product was digested
and cloned into the EcoRI and SalI sites of the pBABE-neo vector
and its sequence was verified by sequencing of both strands.
SENESCENCE ASSOCIATED β-GALACTOSIDASE (SA-β-GAL) ASSAY
Cells were seeded on six well plates (2–4 ×104 per well) and
grown for 24 h prior to staining. SA-β-Gal staining was carried
out at pH 6 as previously described (Dimri et al., 1995; Shlush
et al., 2011) withminormodifications. The cells were washed with
cold PBS, and fixed for 5min with 0.5% glutaraldehyde diluted
in cold PBS. After fixation, cells were washed in PBS and incu-
bated for 8 h at 37◦C with staining solution containing 1mg/ml
5-bromo-4-chloro-3-indolyl- β-D-galactoside (X-Gal) and addi-
tional components as described (Dimri et al., 1995; Shlush et al.,
2011). Following the incubation period at 37◦C, cells were washed
three times for 5min with cold PBS and stored in PBS at 4◦C. 48 h
after staining the cells were photographed and subjected to image
analysis withMatlab using a program developed in our laboratory
(Shlush et al., 2011).
IMMUNOFLUORESCENCE (IF) AND MICROSCOPY ANALYSIS
ICF and control fibroblasts were seeded on coverslips 48–72 h
prior to IF staining. Cells were fixed with 4% paraformaldehyde,
permeabilized with 0.5% Triton in PBS and blocked for 30min
at 37◦C in 3%BSA/ 4XSSC. Following these treatments, slides
were incubated for 1 h at 37◦C with primary antibody diluted in
1%BSA/ 4XSSC, washed three times for 5min in 0.1% Triton/PBS
at RT, and incubated with a secondary antibody for 1 h at 37◦C in
1%BSA/ 4XSSC. Nuclei were stained with Vectashield mounting
medium containing DAPI (Vector Laboratories). Primary anti-
bodies applied for IF were as follows: mouse anti phosphory-
lated γH2AX (#05-636, Upstate), diluted 1:1000, mouse anti p21
(#556430, BD Bioscience), diluted 1:800, mouse anti p16 (sc9968,
SantaCruz), diluted 1:100.
FLUORESCENCEMICROSCOPY
IF was visualized using a BX50 microscope (Olympus). Images
were captured with an Olympus DP70 camera controlled by DP
controller software (Olympus).
TRF ANALYSIS AND DNAMETHYLATION STUDIES BY SOUTHERN
ANALYSIS
Genomic DNA was extracted according to standard procedures.
Purified DNA was subjected to restriction enzyme digestion
and gel electrophoresis. DNA was transferred to a MagnaGraph
nylon transfer membrane (Water and Process Technologies) and
hybridized with the appropriate probes.
Telomere length was determined by TRF analysis following
analysis with MATELO software (Yehezkel et al., 2008, 2011).
Subtelomere-methylation analysis was carried out by utilizing the
NBL-1 and Hutel subtelomeric-repeat probes (Yehezkel et al.,
2008, 2011). The methylation status of satellite 2 and the p1A12
repeat was determined as described previously (Ofir et al., 2002;
Yehezkel et al., 2011).
METHYLATION ANALYSIS BY BISULFITE SEQUENCING
Eight subtelomeric regions were analyzed by bisulfite sequenc-
ing. Genomic DNA (1μg) was bisulfite-converted with the
Methylamp DNA Modification kit (EPIGENTEK, NY) accord-
ing to the manufacturer’s instructions. After bisulfite con-
version, DNA was amplified using Faststart Taq polymerase
(Roche) as follows: 95◦C—4min; 5 cycles of: 95◦C—30 s,
low annealing temperature—3min, 72◦C—3min; 35 cycles
of: 95◦C—30 s, high annealing temperature—30 s, 72◦C—30 s;
72◦C—10min. Primer sequences and high and low annealing
temperatures for each primer set appear in Table 1. PCR prod-
ucts were TA-cloned into either pCR2.1 plasmid (Invitrogen) or
pGEM-T plasmid (Promega). Inserts were sequenced with M13
universal primers.
Chromosomal positions of subtelomeric regions analyzed
previously have been described: subtelomeres 2p and 4p (Ng
et al., 2009) and 5p, 7q, 10q, and Xq (Yehezkel et al.,
2011). The chromosomal positions of amplified regions using
previously unpublished primers are as following: subtelom-
ere 15q—position 102,520,562–102,520,834 (chromosome 15
contig, GRCh37) and subtelomere 16p—position 60,231–60,462
Table 1 | Primers for bisulfite analysis.
Sub-telomere Forward primer Reverse primer Annealing Fragment References
temperaturea size
2p GTATTGTAGGTGTATAGTTGTATAAG TAAAATTCCACCTATCTCTATAC 55/58◦C 128 bp Ng et al., 2009
4p TGGTGTAGATGTAGAGAAGA CTAACTTTTCAAATTACTAAAATTC 52/55◦C 204 bp Ng et al., 2009
5p TTGATTTTGATTATTTAGGGGT AAACAAAATACTCCTCAACACA 55/58◦C 222 bp Yehezkel et al., 2011
7q TTTTTAAGGTTTGTGTTGAGG TCTACACAACCTTTTAAAATAC 53/56◦C 176 bp Yehezkel et al., 2011
10q TAATTGGTTTTTGATTTTGATT CAAAATTCTTCTCAAATCAAAC 54/57◦C 229 bp Yehezkel et al., 2011
15q TTTAGAGGGGTTTTTGTTTTTT ACAAAATTCTCCTCAAATCAAA 56/56◦C 273 bp previously unpublished
16p GTTTTAATTGGTTTTTGATTTTG CAAAATTCTACTCAAATCAAAC 53/56◦C 232 bp previously unpublished
Xq TATTTTGGGTATCATGTGTG GCCACTGACTGGCTTTGGGAC 54/57◦C 253 bp Yehezkel et al., 2011
aPCR following bisulfite conversion utilizes low and high annealing temperatures.
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following oligonucleotides: AAGAATTCATCCCCATGGCGGC
AAGTCGACTCATTTATAAAGAGGAAG (reverse primer con-
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(chromosome 16 contig, GRCh37). All analyzed regions are
located within 400 bp from the telomere tract.
RNA EXTRACTION, NORTHERN BLOT ANALYSIS, AND RT-PCR
RNA was extracted with TRI REAGENT (Molecular Research
Center, Inc.). The RNA pellet was resuspended in DEPC-treated
water containing RNase inhibitor (4U/μl RNasin, Promega)
and treated with DNaseI (#79254, Qiagene). For Northern
analysis, RNA was concentrated on columns (#74204, Qiagene).
Northern analysis for TERRA expression was carried out as
described previously (Yehezkel et al., 2008). Primer sequences
for RT-PCR were as following: DNMT3B: Forward—CCTGCT
GAATTACTCACGCCCC, Reverse—GTCTGTGTAGTGCAC





Samples containing 100–150μg protein were electrophoresed
in Tris-glycine-SDS running buffer on SDS-polyacrylamide gels
(8% for DNMT3B1 and 12% for DNMT3L). DNMT3B was
detected with goat anti DNMT3B diluted 1:750 (T-16, sc-10236,
Santa-Cruz). DNMT3L was detected with goat anti-DNMT3L
diluted 1:700 (N-14, sc-10239, Santa-Cruz). To confirm equal
protein loading, membranes were also reacted with a mouse
anti-tubulin antibody diluted 1:5000 (T-9026, Sigma).
RESULTS
ICF PRIMARY FIBROBLASTS ENTER SENESCENCE AT A LOW
POPULATION DOUBLING
Previously we had shown that telomeres are abnormally short in
lymphoblastoid cells derived from two ICF patients, pCor and pG,
and in primary fibroblast cells from patient pCor (Yehezkel et al.,
2008). Consequently, we asked whether the replicative potential
of ICF primary fibroblasts is reduced in comparison to normal
human fibroblasts.
The pCor primary skin fibroblasts were obtained from a one-
year-old female at PD14.8 and pG fibroblasts originated from a
male ICF patient (Jiang et al., 2005) at age eight and was obtained
by us at passage (P) 9. The estimated PD of pG fibroblasts at
P9 is between 18 and 27 (personal communication with the lab-
oratory that provided the cells). pCor fibroblasts, in addition
to carrying short telomeres, have hypomethylated subtelomeric
and non-subtelomeric repeats, as well as high levels of TERRA
(Yehezkel et al., 2008). We proceeded to examine these char-
acteristics in pG fibroblasts and determined that, similarly to
pCor fibroblasts, they display hypomethylation of various telom-
eric and non-telomeric repetitive regions and high TERRA levels
(Figure 1).
FIGURE 1 | pG fibroblasts display telomeric abnormalities typical to ICF
type I syndrome. (A) Methylation analysis of subtelomeric repeats with
NBL-1 probe. DNA samples were digested with either HpaII (H) or MspI (M)
restriction enzymes. Blots were hybridized with NBL-1 probe. Arrows
point to hybridization bands that appear in HpaII-digested DNA due to
hypomethylation of NBL-1 repeats. NBL-1 repeats are heavily methylated in
Cord Blood DNA (CB), therefore are not digested with HpaII. (B) Methylation
analysis of subtelomeric repeats with Hutel probe. DNA samples were
digested with either SauAI (S) or MboI (Mb) restriction enzymes. Blots were
hybridized with Hutel probe. Arrows point to hybridization bands that appear
in SauAI-digested DNA due to hypomethylation of Hutel repeats. Hutel
repeats, which are heavily methylated in cord blood DNA, are not digested
with SauAI. (C) Methylation analysis of satellite 2 repeats. Following
digestion with BstBI restriction enzyme, DNA was hybridized with a satellite
2 probe. DNA hypomethylated at these repeats is visualized as bands at the
lower molecular range, while methylated satellite 2 repeats appear as high
molecular bands, as demonstrated with CB and primary fibroblast DNA (FSE).
(D) Northern analysis of TERRA expression in pG fibroblasts with and without
expression of ectopic hTERT. Northern analysis was carried out with a C-rich
(TAACCC)3 probe. Hybridization signals to a β-actin probe on the same blot
are shown in the lower panel. The passage (P) and PD at which RNA was
extracted from pG fibroblasts, are indicated blow the blots.
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We passaged pCor and pG fibroblasts until they no longer
proliferated while determining their PD at each passage. pCor
fibroblasts were passaged twice from PD14.8 to approximately
PD26, at which point proliferation ceased (Figure 2A). pG fibrob-
lasts were passaged twice from P9. In one experiment, cells ceased
to proliferate after 13.7 PDs, and in a repeated experiment after
only 7.6 PDs (Figure 2C). Based on the estimated PD at P9
(maximum 27 PDs), pG fibroblasts ceased to proliferate between
37.6 and 40.7 PDs. Control, primary foreskin fibroblasts, FSE,
proliferated for 66–68 PDs (Figure 2A). In comparison to FSE
fibroblasts and additional studies that have shown that fibroblasts
obtained from young healthy individuals enter senescence after
50–100 PD in culture (Harley, 1995; Shall, 1997), both pCor and
pG fibroblasts ceased to proliferate at a strikingly low PD.
In order to study whether ICF fibroblasts exhibit typical char-
acteristics of cellular senescence at the low PD at which they arrest
proliferation, we subjected the cells to the SA-β-Gal (Senescence
Associated β-Galactosidase) assay (Dimri et al., 1995). A com-
puter program designed for quantitating SA-β-Gal staining per
cell and for determining individual cell size, which is typically
larger at senescence, has been developed in our laboratory (Shlush
et al., 2011). Utilizing this quantitative analysis we measured the
degree of SA-β-Gal staining per cell and the cell sizes of pCor and
FSE fibroblasts. Levels of SA-β-Gal staining increased sharply in
pCor fibroblasts as they reached their final PDs and the intensity
of staining was higher than that observed in control fibroblasts
at a later PD (Figure 3A). Mean cell surface area in pCor fibrob-
lasts at PD25 was ∼4.5 fold that of control fibroblasts at PD 30
(Figure 3C).
Cellular senescence is also accompanied by increased DNA
damage signals that are characterized by an elevated number of
γH2AX foci [(D’Adda Di Fagagna et al., 2003) and reviewed in
Herbig and Sedivy (2006) and Lou and Chen (2006)]. We per-
formed IF staining with an anti-γH2AX antibody and scored the
number of γH2AX foci in pCor and pG fibroblasts at two differ-
ent PDs. γH2AX foci were scored also in control fibroblasts (FSE)
at early and more advanced PDs (Figures 4A,B). pCor fibroblasts
displayed γH2AX foci in over 90% of the cells at PD25, while in
pG fibroblasts over 70% showed γH2AX foci at PD40. In com-
parison, control FSE fibroblasts displayed γH2AX foci in less than
50% of the cells at a more advanced PD (PD62). Notably, γH2AX
foci appear in ICF fibroblasts at a PD at which normal fibroblasts
are almost devoid of this senescence marker (D’Adda Di Fagagna
et al., 2003).
Replicative senescence is also strongly correlated with up reg-
ulation of p21 and of p16 in certain cell types (Alcorta et al.,
FIGURE 2 | ICF primary fibroblasts enter senescence at a low
population doubling. Growth curves of control FSE (A) pCor
(B) and pG (C) fibroblasts passaged twice in culture until
senescence. pCor fibroblasts were passaged from PD 14.8 to
senescence, and pG fibroblasts were passaged from passage
nine to senescence.
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FIGURE 3 | ICF fibroblasts display high levels of SA-β-Gal staining
and large cell surface at a relatively low population doubling.
(A) SA-β-Gal assay was performed on FSE and pCor fibroblasts at
different PDs and the average blue staining intensity was determined by
quantitative software, as described (Shlush et al., 2011). The average
intensity at each PD is displayed in arbitrary units (AU). (B) Two fields of
pCor fibroblasts at different PDs, stained by the SA-β-Gal assay. (C) Cells
stained for SA-β-Gal were analyzed for average cell surface size at each
PD. The graph displays the average area in normalized arbitrary units (AU)
at different PDs.
1996; Herbig et al., 2004). We examined the expression of these
proteins by IF in the ICF fibroblasts and control FSE fibroblasts.
We classified the cells according to four levels of p21 expression:
absent, low, medium and high and determined the percentage of
cells in each group. High levels of p21 expression were detected
in over 90% of nuclei in pCor fibroblasts at PD22.5 and over
80% in pG at PD40 (Figures 4C,D). In comparison, in control
FSE less than 20% of the cells expressed high levels of p21 at
PD42 and in over 40% of the nuclei no expression of p21 was
detected by IF. p16 expression was not detected in ICF fibroblasts
at any stage of growth, as shown previously in normal fibroblasts
(Herbig et al., 2004). Taken together, these findings indicate that
premature senescence occurs in primary ICF fibroblasts grown in
culture.
PREMATURE SENESCENCE OF ICF-FIBROBLASTS CAN BE RESCUED BY
THE EXPRESSIONOF hTERT
Telomere Restriction Fragment (TRF) analysis was performed on
DNA obtained from pCor and pG fibroblasts at different PDs.
In pCor fibroblasts, at the earliest PD tested, PD 17.6, mean
telomere length (MTL) was already extremely low (5.8 kb) and at
senescence (PD26) the MTL was 5.4 kb (Figure 5A). TRF anal-
ysis of pG fibroblasts at P9 + PD5 also showed a low MTL
of 5.6 kb (Figure 5B). These findings indicate that in both ICF-
fibroblasts, premature senescence at a low PD is accompanied by
a reduced MTL.
In order to determine whether senescence is indeed induced
by telomere shortening, or alternatively by the hypomethylated
state of the subtelomeres, we attempted to elongate telomeres in
ICF fibroblasts by ectopically expressing the catalytic subunit of
telomerase, hTERT, in these cells. We first determined whether
subtelomeres remained unmethylated after expression of ectopic
hTERT. This was carried out by Southern analysis utilizing the
isoschizomeric restriction enzymes MspI (methylation insensi-
tive) andHpaII (methylation sensitive) and probes that recognize
repetitive regions in subtelomeres (Hutel and NBL-1) (Yehezkel
et al., 2008, 2011). Following hTERT expression, subtelomeres
were still hypomethylated in pCor (Yehezkel et al., 2008) and in
pG fibroblasts (Figures 5C,D) to the same degree as prior to the
introduction of hTERT. Both cells types elongated their telomeres
(Yehezkel et al., 2008) (Figure 5B) and were rescued from prolif-
erative arrest. Control pCor fibroblasts, transduced with an empty
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FIGURE 4 | ICF fibroblasts display high levels of γ-H2AX foci and p21
staining at abnormally low population doublings. (A) pCor, pG and FSE
fibroblasts with and without expression of hTERT were stained with an
antibody to γ-H2AX. Cells were scored for the number of nuclear foci.
(B) Representative pCor nuclei at PDs 22.5 and 25.2 illustrate γ-H2AX foci.
(C) pCor, pG, and FSE fibroblasts with and without expression of hTERT were
stained with an antibody for p21 and were scored for staining intensity. (D)
Representative pCor nuclei at PD 17.6 and 25.2 demonstrating p21 staining.
vector, entered senescence at approximately PD25, similar to the
PD at which the untransduced cells entered senescence (results
not shown).
γH2AX foci were scored in pCor and pG fibroblasts rescued
from senescence by hTERT, and in immortalized FSE fibrob-
lasts (FSE + hTERT). The FSE fibroblasts were transduced with
hTERT at a PD very close to senescence. The γH2AX foci
decreased in ICF and FSE fibroblasts following ectopic expres-
sion of hTERT (Figure 4A) and reached less than 30% and 20%
for pCor and pG, respectively. Similarly, levels of p21 expression
decreased in both ICF andWT fibroblasts introduced with hTERT
(Figure 4C). Collectively these findings suggest that telomere
shortening per se, and not the hypomethylated state of the sub-
telomeric regions, triggers the early entrance into senescence.
ECTOPIC EXPRESSION OF WT DNMT3B1 IN ICF FIBROBLAST CELLS
DOES NOT RESTORE NORMAL METHYLATION PATTERNS AT
REPETITIVE REGIONS
DNMT3B is responsible for de novo methylation of subtelom-
eric regions, as well as additional repetitive sequences during early
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FIGURE 5 | Premature senescence is associated with short telomere
length in ICF fibroblasts. (A) TRF analysis of pCor fibroblasts at different
PDs (which appear above the lanes). Mean telomere length (MTL) as
determined by MATELO software are indicated below the lanes. Size
markers in kb are shown to the left of the blot. (B) TRF analysis of pG
fibroblasts with and without expression of ectopic hTERT. The PD at which
DNA was extracted from the cells and the MTL in kb as determined by
MATELO software, appear below the blot. (C) Methylation analysis of
subtelomeric repeats with NBL-1 probe in pG and pCor fibroblasts after
immortalization with hTERT. DNA samples were digested with either HpaII
(H) or MspI (M) restriction enzymes. Blots were hybridized with NBL-1 probe.
Arrows point to hybridization bands that appear in HpaII-digested DNA due to
hypomethylation of NBL-1 repeats. (D) Methylation analysis of subtelomeric
repeats with Hutel probe in pG and pCor fibroblasts after immortalization
with hTERT. DNA samples were digested with either SauAI (S) or MboI (Mb)
restriction enzymes. Blots were hybridized with Hutel probe. Arrows point to
hybridization bands that appear in SauAI-digested DNA due to
hypomethylation of Hutel repeats.
embryonic development (Okano et al., 1999b; Chen et al., 2003;
Ueda et al., 2006; Yehezkel et al., 2008). In mice, expression of
full length Dnmt3b in Dnmt3a/b−/− mES or Dnmt3b−/− MEF
cells has been reported to restore methylation at minor satellite
repeats, a specific target of Dnmt3b (Chen et al., 2003; Dodge
et al., 2005). Accordingly, we asked whether de novo methyla-
tion of DNMT3B-target repetitive genomic regions also occurs in
human ICF syndrome fibroblasts.
DNMT3B has several isoforms emanating from alternative
splicing. The prevalent isoform expressed during early embryonic
development is the full-length isoform, DNMT3B1 (Huntriss
et al., 2004). Human fibroblasts express predominantly the
DNMT3B3 isoform RNA, lacking two exons encoding for the cat-
alytic domain of the enzyme, and weakly express this isoform at
the protein level (Weisenberger et al., 2004). pCor fibroblasts were
shown previously to similarly transcribe predominantly the 3B3
isoform, however, almost no protein was detected in these cells by
Western analysis (Weisenberger et al., 2004). Because ICF fibrob-
lasts have a limited replicative potential which would not enable
the process of transduction and selection before they entered
senescence, we introduced humanDNMT3B1 (hDNMT3B1) into
ICF pCor and pG fibroblasts that had been immortalized pre-
viously with hTERT. Control ICF fibroblasts were transduced
with an empty vector pcl and ectopic hDMT3B1 expression
was verified (Figures 6A,B). Expression analyses confirmed that
the full-length isoform was detected only in the cells that were
transduced with the full-length WT copy of the gene.
We next determined in the DNMT3B1-expressing cells the
methylation status of subtelomeric regions by Southern analysis
of methylation with the two subtelomeric repeat probes described
previously; NBL-1 (Figure 6C) and Hutel (Figure 6D) (Yehezkel
et al., 2008, 2011). In addition we determined the methylation
of two non-subtelomeric repetitive regions with satellite 2 and
p1A12 probes (Yehezkel et al., 2011) (Figures 6E,F). These analy-
ses demonstrated that methylation was not restored at any of the
human repetitive sequence regions examined in both ICF patient
fibroblasts.
Previously we have shown the advantages of assessing methy-
lation levels by bisulfite analysis in addition to Southern analysis
(Yehezkel et al., 2011). Using bisulfite analysis, we had previ-
ously determined the subtelomeric methylation at several sub-
telomeres and found significantly lower methylation levels in
ICF fibroblasts in comparison to wild type fibroblasts (FSE)
(Yehezkel et al., 2011). Here we analyzed two additional sub-
telomeres, 15q and 16p, and found that they also show dramat-
ically low levels of methylation in pCor fibroblasts (18.6 and
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FIGURE 6 | The abnormal methylation state of subtelomeric regions
and other non-telomeric repetitive sequences is not rescued by
human DNMT3B1 in ICF fibroblasts. (A) RT-PCR analysis of DNMT3B1
mRNA expression in immortalized pG and pCor fibroblasts introduced with
either an empty plasmid as a control (pcl) or DNMT3B1 (3B1). DNMT3B
has several isoforms as a result of alternative splicing. The most prevalent
isoforms are: DNMT3B1 (3B1), DNMT3B2 (3B2), and DNMT3B3 (3B3). The
full-length 3B1 is highly expressed only in the immortalized ICF fibroblasts
that have been transduced with the full-length cDNA. Size markers in kb
appear to the right of the gel. β-actin was amplified as a control. (B)
Western blot analysis of DNMT3B expression in immortalized pCor
fibroblasts, which were transduced with either the empty plasmid (pcl) or
hDNMT3B1 (3B1). DNMT3B1 (3B1) appears clearly only in the cells
introduced with the full-length isoform of DNMT3B. Size markers in KD
appear on the left of the blot. α-Tubulin serves as a control for equal
protein loading. (C) Methylation analysis of pCor + hTERT + DNMT3B1
and pG + hTERT + DNMT3B1 fibroblasts with the subtelomeric NBL-1
probe following digestion of DNA samples with HpaII (H) and MspI (M).
Arrows point to hybridization bands in samples that are hypomethylated
and therefore appear in HpaII-digested DNA in addition to MspI-digested
DNA. (D) Methylation analysis of pCor + hTERT + DNMT3B1 and pG +
hTERT + DNMT3B1 fibroblasts with the subtelomeric Hutel probe. DNA
samples were digested with either Sau3AI (S) or MboI (Mb) and probed
with the subtelomeric Hutel probe. Arrows point to hybridization bands in
samples that are hypomethylated and therefore appear in Sau3AI-digested
DNA in addition to MboI-digested DNA. (E) Methylation analysis of pCor +
hTERT + DNMT3B1 and pG + hTERT + DNMT3B1 fibroblasts with the
p1A12 probe. DNA samples were digested initially with MseI, followed by
redigestion with either MspI (M) or HpaII (H) and separated on a 2%
agarose gel. If the DNA is hypomethylated (as in sperm DNA), the
additional digestion with HpaII produces smaller bands, as with MspI. Cord
Blood (CB) DNA is methylated at 1A12 repeats. (F) Methylation analysis of
pCor + hTERT + DNMT3B1 and pG + hTERT + DNMT3B1 fibroblasts
with the Satellite 2 repeat probe following digestion of DNA samples with
BstBI. The hypomethylated samples are visualized by the appearance of
bands at the lower molecular range.
7.6%, respectively) in comparison to FSE fibroblasts (76.8 and
82.6% respectively) (Figure 7A, Table A1, Figure A1). We then
tested whether the introduction of hTERT into the pCor fibrob-
lasts influenced the methylation levels at these subtelomeres.
The methylation percentages of each subtelomere were compared
between the pCor fibroblasts and the pCor + hTERT fibroblasts
and analyzed statistically using a χ2-test with Yate’s correction.
This analysis (Figures 7B,D, Table A1, Figures A2–A9) showed
that methylation at one subtelomere (7q) was significantly ele-
vated in the immortalized cells and methylation at subtelomere
15q was significantly reduced. The remaining five subtelom-
eric regions did not alter their methylation levels significantly
(Figure 7B).
We next performed bisulfite analysis on these subtelomeres in
hTERT-immortalized pCor fibroblasts that were transduced with
the WT copy of DNMT3B1. As shown in Figure 7C, all analyzed
subtelomeres, with exception of subtelomere 4p, maintained the
hypomethylated state, indicating that remethylation of subtelom-
eric regions cannot be carried out in ICF somatic fibroblasts by
expression of WT hDNMT3B1 alone.
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FIGURE 7 | Bisulfite analysis of subtelomeric methylation in ICF
fibroblasts. pCor fibroblasts were subjected to bisulfite analysis at eight
subtelomeric regions (2p, 4p, 5p, 7q, 10q, 15q, 16p, and Xq), within
400bp from the respective telomeric track. Regions are depicted in
graphs by chromosome number only, but refer only to the specified
chromosome arm. Bisulfite analysis data appears in Figures A1–A9 and
in Table A1. (A) Comparison of subtelomeric methylation levels between
WT (FSE) and ICF (pCor) fibroblasts. (B) Comparison of subtelomeric
methylation levels between pCor fibroblasts and pCor + hTERT
fibroblasts. (C) Comparison of subtelomeric methylation levels between
pCor + hTERT, pCor + hTERT + DNMT3B1 (3B1) and pCor + hTERT +
DNMT3B1 + DNMT3L (3L) fibroblasts. (D) Summary of p-values obtained
by a χ2-test with Yate’s correction. pCor/+hTERT: comparison of
methylation percentage between pCor and pCor + hTERT, hTERT/+3B1:
comparison of methylation percentage between pCor + hTERT to
pCor + hTERT + DNMT3B1. 3B1/3L: comparison of methylation
percentage between pCor + hTERT + DNMT3B1 and pCor + hTERT +
DNMT3B1 + DNMT3L. Arrows depict whether in the cases of significant
methylation-level changes the methylation percentage was elevated or
reduced.
ECTOPIC EXPRESSION OF WT DNMT3B1 IN CONCERTWITH DNMT3L
IN ICF FIBROBLASTS PARTIALLY RESTORESMETHYLATION LEVELS AT
SUBTELOMERIC REGIONS
The failure to restore methylation levels by expression of WT
hDNMT3B1 suggested that de novo methylation of the repetitive
target regions of this enzyme, may be possible only during early
development when additional factors involved in this process
are present. One such candidate factor is DNMT3L, a co-factor
of DNMT3A and 3B that is up-regulated during early embry-
onic development at stages in which de novo methylation occurs
(Huntriss et al., 2004; Hu et al., 2008). To determine whether
the expression of DNMT3L concomitantly with DNMT3B1 is
sufficient to de novomethylate repetitive sequences in ICF fibrob-
lasts, we further introduced DNMT3L into immortalized pCor
fibroblasts that expressed hDNMT3B1. Control cells were trans-
duced with an empty vector. After verification of DNMT3L
expression by RT-PCR and Western blotting (Figures 8A,B), we
performed Southern analysis with the two subtelomeric repeat
probes NBL-1 and Hutel and the two additional non-telomeric
repetitive sequence probes: Satellite 2 and p1A12 (Figures 8C–F).
These analyses revealed that simultaneous expression of both
DNMT3B1 and DNMT3L does not result in remethylation
of DNMT3B1 target repetitive sequences, to a degree that is
detectable by Southern analysis.
We complemented this analysis with bisulfite analysis of the
eight subtelomeric regions studied previously. Surprisingly, this
analysis revealed that in five out of the eight subtelomeric regions,
methylation levels were significantly increased (Figures 7C,D).
However, the methylation levels were still lower in comparison to
FSE fibroblasts (Figure 7A, Table A1), indicating that concomi-
tant expression of DNMT3L in ICF fibroblasts is still not sufficient
to restore subtelomeric methylation to levels observed in WT
fibroblasts.
DISCUSSION
In addition to the three hallmarks that define ICF
syndrome—immunodeficiency, centromeric instability and
facial anomalies, telomeric abnormalities are an additional
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FIGURE 8 | Methylation of subtelomeric regions and other
non-telomeric repetitive sequences, as determined by Southern
analysis, following co-expression of human DNMT3B1 and DNMT3L in
ICF fibroblasts. (A) RT-PCR analysis of DNMT3L mRNA expression in pCor
+ hTERT + DNMT3B1 fibroblasts introduced with either DNMT3L
(DNMT3L) or with an empty plasmid (pBABE) (left panel). Size markers in kb
appear to the left of the blot. β-actin was amplified as a control (right panel).
(B) Western blot analysis of DNMT3L expression in pCor + hTERT +
DNMT3B1 fibroblasts, which were transduced with either hDNMT3L or the
empty plasmid (pBABE). α-Tubulin serves as a control for equal protein
loading. (C) Methylation analysis of pCor + hTERT + DNMT3B1 + DNMT3L
(DNMT3L) and pCor + hTERT + DNMT3B1 + pBABE (pBABE) fibroblasts
with the subtelomeric NBL-1 probe following digestion of DNA samples
with HpaII (H) and MspI (M). Arrows point to hybridization bands in samples
that are hypomethylated and therefore appear in HpaII-digested DNA in
addition to MspI-digested DNA. (D) Methylation analysis of pCor + hTERT +
DNMT3B1 + DNMT3L (DNMT3L) and pCor + hTERT + DNMT3B1 +
pBABE (pBABE) fibroblasts with the subtelomeric Hutel probe. DNA
samples were digested with either Sau3AI (S) or MboI (Mb) and probed
with the subtelomeric Hutel probe. Arrows point to hybridization bands in
samples that are hypomethylated and therefore appear in Sau3AI-digested
DNA in addition to MboI-digested DNA. (E) Methylation analysis of pCor +
hTERT + DNMT3B1 + DNMT3L (DNMT3L) and pCor + hTERT + DNMT3B1
+ pBABE (pBABE) fibroblasts with the p1A12 probe. DNA samples were
digested initially with MseI, followed by redigestion with either MspI or
HpaII and separated on a 2% agarose gel. Hypomethylation is visualized as
an HpaII- hybridization pattern similar to that achieved with MspI- digestion.
(F) Methylation analysis of pCor + hTERT + DNMT3B1 + DNMT3L
(DNMT3L) and pCor + hTERT + DNMT3B1 + pBABE (pBABE) fibroblasts
with the Satellite 2 repeat probe following digestion of DNA samples with
BstBI. The hypomethylated samples are visualized by the appearance of
bands at the lower molecular range.
phenotypic feature of this syndrome (Yehezkel et al., 2008;
Deng et al., 2010). Here we extend our previous analysis of
telomeric abnormalities in ICF syndrome type I and describe the
consequences of abnormal telomere shortening in ICF syndrome
type I primary fibroblasts.
Abnormally short telomere lengths indicate the potential
for premature senescence, as demonstrated previously in other
genetic diseases such as DKC (Wong and Collins, 2006),
Werner syndrome (Wyllie et al., 2000) and ataxia–telangiectasia
(Tchirkov and Lansdorp, 2003). We studied ICF fibroblasts from
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two patients and found that indeed they entered senescence at a
significantly earlier PD in comparison to the PD at which normal
primary fibroblasts enter senescence when passaged in culture
(Harley, 1995; Shall, 1997) (Figure 2). Senescence in ICF fibrob-
lasts is characterized by several markers including expression of
p21, γH2AX foci, SA-β-Gal staining and a large cell volume
(Bodnar et al., 1998; Herbig et al., 2004) (Figures 3, 4). All of these
markers appeared in ICF fibroblasts at PDs at which normal cells
are almost devoid of senescence markers.
We asked whether the premature senescence in human ICF
fibroblasts is indeed linked to telomere dysfunction either as the
direct consequence of short telomere length, or alternatively by
an effect of subtelomeric hypomethylation on telomere integrity
and functionality, with no relation to telomere length. This alter-
native could not be ruled out since in Dnmt3a/b−/− MEFs,
subtelomeric hypomethylation leads to telomeric abnormalities
in the presence of long telomeres (Gonzalo et al., 2006). In addi-
tion, abnormal telomere shortening and premature senescence
have been demonstrated in fibroblasts of patients affected by
additional human genetic diseases (Wyllie et al., 2000; Tchirkov
and Lansdorp, 2003; Crabbe et al., 2004; Westin et al., 2007).
Attempts to rescue these cells from senescence by ectopic expres-
sion of hTERT succeeded in several instances (Wyllie et al., 2000;
Crabbe et al., 2004; Naka et al., 2004; Westin et al., 2007) but
not in all [(Wong and Collins, 2006), and in fibroblasts from
a Hoyeraal–Hreidarsson syndrome patient—Y. Tzfati—personal
communication]. In ICF fibroblasts we found that expression of
ectopic hTERT lengthened telomeres that remained hypomethy-
lated at subtelomeres, but all the hallmarks of senescence were
reversed. These findings indicate that senescence was induced in
ICF fibroblasts due to critically short telomere length per se and
not due to hypomethylation at subtelomeric regions or another
telomere capping defect.
Telomeres in both ICF patients’ fibroblasts were abnormally
short, already at a very low PD. In the case of pCor patient,
the fibroblasts were obtained at an age of 1 year and neverthe-
less the MTL was less than 6 kb at PD 18. A similar MTL was
demonstrated in fibroblasts obtained at age eight from patient
pG, at an estimated PD of between 23 and 32. This suggests that
telomeres are not maintained properly during embryonic devel-
opment, resulting in relatively short telomeres in early infancy
and childhood. However, the consequences of short telomere
length in ICF patients early on in life have not been previ-
ously considered when attempting to understand the molecular
pathology leading to immunodeficiency and other phenotypic
components of the syndrome. In contrast to DKC, in which short
telomere length clearly leads to stem cell exhaustion, leading to
immunodeficiency (Westin et al., 2007), in ICF syndrome the
immunodeficiency is usually manifested as agammaglobuline-
mia in the presence of normal B- and T- cell counts in most,
but not all, patients (Ehrlich, 2003; Hagleitner et al., 2008). It
has been suggested that specific genes, dysregulated by abnor-
mal methylation, are the driving force in the development of
the aberrant phenotype in this syndrome. Several studies have
unveiled such genes that are up or down regulated in ICF syn-
drome type I, among them genes involved in the immune system
and lymphocyte development (reviewed in Walton et al., 2011).
Notably, no correlation was found between the transcription
levels of these genes and methylation changes in their promot-
ers. However, the involvement of specific genes in the molecular
pathology of the disease does not rule out the possibility that
abnormal telomere length is linked as well to the abnormal phe-
notype. Considering such a possibility and taking in account
that hTERT expression rescues ICF fibroblasts from senescence,
ectopic expression of telomerase in hematopoietic stem cells may
be a possible strategy for treatment of the immunodeficiency in
ICF syndrome, as suggested for treatment of DKC (Westin et al.,
2007).
Interestingly, in DKC patients, although telomeres are always
abnormally short, a correlation was found between subtelomeric
hypermethylation and relatively longer telomere length (Gadalla
et al., 2012). The abnormal short telomere length phenotype
observed in ICF syndrome is associated with drastic hypomethy-
lation of subtelomeric regions, and the exact mechanism behind
this association is as yet unclear in neither of the diseases. It
could be expected that if normal subtelomeric methylation levels
were restored in ICF syndrome, telomere lengths may also recover
to normal size. In this study we investigated whether rescue of
the abnormal DNA methylation pattern in identified DNMT3B-
target repetitive regions can be achieved in non-embryonic ICF
fibroblasts.
We therefore introduced into immortalized ICF fibroblasts the
full-length isoform of DNMT3B (DNMT3B1), which contains
the catalytic domain and is the predominant isoform expressed
during early embryonic development (Huntriss et al., 2004). We
then examined the methylation status of subtelomeric regions by
Southern and bisulfite analysis, as well as the methylation of two
additional non-telomeric repetitive regions, by Southern anal-
ysis. In all cases, no remethylation was detectable by Southern
analysis (Figure 6). Bisulfite analysis, that allows methylation pat-
terns of specific genomic regions to be analyzed in more detail,
demonstrated partial, but significant, rescue of methylation in
only one out of eight analyzed subtelomeric regions (Figure 7C).
In contrast to these findings, others have found that introduc-
tion of Dnmt3b1 into Dnmt3a/b−/− mES or Dnmt3b−/− MEFs,
restored methylation at minor satellite repeats, a specific target
of Dnmt3b (Chen et al., 2003; Dodge et al., 2005). Likewise,
expression of Dnmts in Dicer1-null mES cells restored global
methylation as well as subtelomeric methylation (Benetti et al.,
2008). These conflicting findings may be explained by the fact
that unlike the mES and MEF cells in which rescue succeeded,
and which are of embryonic origin, the ICF fibroblast cells stud-
ied here originated from post developmental cells. An additional
explanation may be that the dynamics and possibility of de novo
methylation by DNMT3B are dissimilar between human and
mouse cells.
Although traditionally considered as only a de novo DNMT,
more recently DNMT3B and DNMT3A have been shown to play
a role in maintenance methylation in somatic cells, especially at
highly methylated regions such as repetitive elements (reviewed
in Jones and Liang, 2009). The maintenance role of DNMT3B
may explain the decline in methylation in five out of the eight
analyzed subtelomeric regions in the ICF fibroblasts immortal-
ized with hTERT after culturing for over 50 PDs (Figure 7B).
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The DNMT3B-dependent maintenance of methylation suggests
that, similar to the ICF cells grown in culture, a decline in
methylation may be expected also in the patients’ cells over
time, even during embryonic development. The affected regions
could potentially include both repetitive elements, and specific
genes, as findings from previous studies suggest that certain genes
rely on DNMT3B for both establishing and maintaining their
methylation patterns (reviewed in Walton et al., 2011).
The de novo methylation process occurs during early embry-
onic development (Borgel et al., 2010), and presumably involves
factors that are essential for DNMT3B activity. Expression of
cooperating factors restricted to this developmental window
may lead to establishment of methylation patterns of certain
genomic areas exclusively during early embryonic stages. One
of the key regulators of the de novo DNMTs is DNMT3L
(Suetake et al., 2004; Chen et al., 2005; Gowher et al., 2005).
This co-factor is highly expressed throughout the developmen-
tal stages during which de novo methylation occurs (Huntriss
et al., 2004; Hu et al., 2008). We therefore asked whether ectopic
expression of this co-factor in the ICF DNMT3B1-expressing
fibroblasts might promote de novo subtelomeric methylation.
Southern analyses did not detect de novo methylation in these
cells of either subtelomeric regions or other non-telomeric repet-
itive regions (Figure 8). However, of interest, bisulfite analysis
demonstrated that in seven of the eight subtelomeres analyzed,
methylation was partially rescued in the region up to 400 bps
adjacent to the telomeric repeats (Figure 7C). This change was
statistically significant in six of these subtelomeres (Figure 7D).
The only subtelomere whose methylation was unaffected by the
introduction of DNMT3L (subtelomere 7q) had demonstrated
significant methylation restoration following the introduction
of hTERT. This suggests that expression of DNMT3L can stim-
ulate DNMT3B and lead to de novo methylation of its target
sequences at subtelomeric regions, albeit to levels significantly
lower than those observed in control fibroblasts. Additional fac-
tors that may be present during the critical time period at
which de novo methylation is carried out, may be required in
order to mimic the developmental progress and achieve the full
restoration of subtelomeric methylation. This may also explain
why rescue of abnormal methylation was observed in mutant
mES cells (Chen et al., 2003) and in mES after treatment with
5-azacytidine (Liang et al., 2002). Studying methylation res-
cue in ICF cells in a molecular environment mimicking early
development stages may facilitate the detection of additional
factors required for normal de novo methylation by DNMT3B.
The recent advances that enable the generation of pluripotent
stem cells from patient fibroblasts, may present the appropri-
ate platform to fully understand the molecular pathology of ICF
syndrome.
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APPENDIX
Table A1 | Bisulfite analysis data.
Number of Total analyzed % methylation
methylated sites sites
Tel 2p
FSE 129 195 66.1
pCor 5 169 3.0
+hTERT 16 220 7.3
+hTERT/3B 5 143 3.5
+hTERT/3B/3L 28 386 7.2
Tel 4p
FSE 351 444 79.0
pCor 69 339 20.3
+hTERT 36 219 16.4
+hTERT/3B 171 600 28.5
+hTERT/3B/3L 126 331 38.1
Tel 5p
FSE 89 117 76.0
pCor 9 169 5.3
+hTERT 6 159 3.8
+hTERT/3B 7 194 3.6
+hTERT/3B/3L 23 177 13.0
Tel 7q
FSE 127 190 66.8
pCor 79 336 23.5
+hTERT 43 102 42.2
+hTERT/3B 56 117 47.9
+hTERT/3B/3L 179 359 49.9
Tel 10q
FSE 204 243 83.9
pCor 35 377 9.3
+hTERT 15 187 8.0
+hTERT/3B 7 302 2.3
+hTERT/3B/3L 46 133 34.6
Tel 15q
FSE 162 211 76.8
pCor 59 317 18.6
+hTERT 9 155 5.8
+hTERT/3B 6 120 5.0
+hTERT/3B/3L 43 130 33.1
Tel 16p
FSE 100 121 82.6
pCor 8 105 7.6
+hTERT 9 134 6.7
+hTERT/3B 17 143 11.9
+hTERT/3B/3L 32 157 20.4
Tel Xq
FSE 124 168 73.8
pCor 4 312 1.3
+hTERT 5 104 4.8
+hTERT/3B 14 246 5.7
+hTERT/3B/3L 26 200 13.0
FIGURE A1 | Bisulfite analysis of subtelomeric regions 15q and 16p in
WT FSE fibroblast. Bisulfite sequence analysis was carried out for a region
in subtelomeres 15q and 16p. The analyzed regions contain 17CpG sites in
15q subtelomere and 11CpG sites in subtelomere 16p. White circles
represent unmethylated CpG dinucleotides and black circles represent
methylated CpG dinucleotides. Gray circles represent CpG sites that were
converted to CpA or TpA, as occasionally can be observed. Each row is
derived from an individual subclone. Percent of CpG methylation appears
below the cell type.
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FIGURE A2 | Bisulfite analysis of subtelomeric region 2p. Bisulfite
sequence analysis was carried out for a region in subtelomere 2p
in pCor, pCor + hTERT, pCor + hTERT + DNMT3B1 and pCor +
hTERT + DNMT3B1 + DNMT3L fibroblasts. The analyzed region
contains 13 CpG sites. White circles represent unmethylated CpG
dinucleotides and black circles represent methylated CpG
dinucleotides. Gray circles represent CpG sites that were converted
to CpA or TpA, as occasionally can be observed. Each row is
derived from an individual subclone. Percent of CpG methylation
appears below the cell type.
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FIGURE A3 | Bisulfite analysis of subtelomeric region 4p. Bisulfite
sequence analysis was carried out for a region in subtelomere 4p in
pCor, pCor + hTERT, pCor + hTERT + DNMT3B1 and pCor +
hTERT + DNMT3B1 + DNMT3L fibroblasts. The analyzed region
contains 32 CpG sites. White circles represent unmethylated CpG
dinucleotides and black circles represent methylated CpG
dinucleotides. Gray circles represent CpG sites that were converted
to CpA or TpA, as occasionally can be observed. Each row is
derived from an individual subclone. Percent of CpG methylation
appears below the cell type.
FIGURE A4 | Bisulfite analysis of subtelomeric region 5p. Bisulfite
sequence analysis was carried out for a region in subtelomere 5p in
pCor, pCor + hTERT, pCor + hTERT + DNMT3B1 and pCor +
hTERT + DNMT3B1 + DNMT3L fibroblasts. The analyzed region
contains 13 CpG sites. White circles represent unmethylated CpG
dinucleotides and black circles represent methylated CpG
dinucleotides. Gray circles represent CpG sites that were converted
to CpA or TpA, as occasionally can be observed. Each row is
derived from an individual subclone. Percent of CpG methylation
appears below the cell type.
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FIGURE A5 | Bisulfite analysis of subtelomeric region 7q. Bisulfite
sequence analysis was carried out for a region in subtelomere 7q in
pCor, pCor + hTERT, pCor + hTERT + DNMT3B1 and pCor +
hTERT + DNMT3B1 + DNMT3L fibroblasts. The analyzed region
contains 15 CpG sites. White circles represent unmethylated CpG
dinucleotides and black circles represent methylated CpG
dinucleotides. Gray circles represent CpG sites that were converted
to CpA or TpA, as occasionally can be observed. Each row is
derived from an individual subclone. Percent of CpG methylation
appears below the cell type.
FIGURE A6 | Bisulfite analysis of subtelomeric region 10q. Bisulfite
sequence analysis was carried out for a region in subtelomere 10q
in pCor, pCor + hTERT, pCor + hTERT + DNMT3B1 and pCor +
hTERT + DNMT3B1 + DNMT3L fibroblasts. The analyzed region
contains 15 CpG sites. White circles represent unmethylated CpG
dinucleotides and black circles represent methylated CpG
dinucleotides. Gray circles represent CpG sites that were converted
to CpA or TpA, as occasionally can be observed. Each row is
derived from an individual subclone. Percent of CpG methylation
appears below the cell type.
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FIGURE A7 | Bisulfite analysis of subtelomeric region 15q. Bisulfite
sequence analysis was carried out for a region in subtelomere 15q
in pCor, pCor + hTERT, pCor + hTERT + DNMT3B1 and pCor +
hTERT + DNMT3B1 + DNMT3L fibroblasts. The analyzed region
contains 17 CpG sites. White circles represent unmethylated CpG
dinucleotides and black circles represent methylated CpG
dinucleotides. Gray circles represent CpG sites that were converted
to CpA or TpA, as occasionally can be observed. Each row is
derived from an individual subclone. Percent of CpG methylation
appears below the cell type.
FIGURE A8 | Bisulfite analysis of subtelomeric region 16p. Bisulfite
sequence analysis was carried out for a region in subtelomere 16p
in pCor, pCor + hTERT, pCor + hTERT + DNMT3B1 and pCor +
hTERT + DNMT3B1 + DNMT3L fibroblasts. The analyzed region
contains 11 CpG sites. White circles represent unmethylated CpG
dinucleotides and black circles represent methylated CpG
dinucleotides. Gray circles represent CpG sites that were converted
to CpA or TpA, as occasionally can be observed. Each row is
derived from an individual subclone. Percent of CpG methylation
appears below the cell type.
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FIGURE A9 | Bisulfite analysis of subtelomeric region Xq. Bisulfite
sequence analysis was carried out for a region in subtelomere Xq in
pCor, pCor + hTERT, pCor + hTERT + DNMT3B 1 and pCor +
hTERT + DNMT3B 1 + DNMT3L fibroblasts. The analyzed region
contains 12 CpG sites. White circles represent unmethylated CpG
dinucleotides and black circles represent methylated CpG
dinucleotides. Gray circles represent CpG sites that were converted
to CpA or TpA, as occasionally can be observed. Each row is
derived from an individual subclone. Percent of CpG methylation
appears below the cell type.
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